Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cambridge Consultants to Unveil New Licensing Program For Dry Powder Inhaler 'Gen-X' Development Tools and Technology at the Respiratory Drug Delivery Conference.


Development Platform Dramatically Reduces Time-to-Market for Inhalable Drug Delivery Products

CAMBRIDGE, Mass. -- Accelerating the creation of new inhalable drug delivery devices, Cambridge Consultants (www.cambridgeconsultants.com) is announcing the licensing of a range of technology development tools today at the Respiratory Drug Delivery Conference in Scottsdale, Ariz. The company's Gen-X series of technologies, from de-agglomeration for fine particle doses (FPD (1) (Flat Panel Display) See LCD, plasma display, EL display, FED and flat panel display.

(2) (Field Programmable Device) An umbrella term for all chips that can be programmed by the customer including SPLDs, CPLDs and FPGAs. See PLD.
) to drug storage chamber piercing and evacuation evacuation /evac·u·a·tion/ (e-vak?u-a´shun)
1. an emptying.

2. catharsis; emptying of the bowels.


e·vac·u·a·tion
n.
 techniques, draw on the scientific and engineering expertise of being involved in the development of more than 16 respiratory delivery devices over the past 15 years.

"In an industry where the time-to-market for inhalable dry powder Dry Powder

A slang term for cash reserves kept on hand to cover future obligations.

Notes:
For example, if a venture capitalist expects bad times in the IPO markets you might hear him say something like, "we want to keep enough dry powder around to keep funding our
 drug delivery devices is often seven to 10 years, fast-tracking development with our proven Gen-X development platform can significantly reduce this timescale timescale
Noun

the period of time within which events occur or are due to occur

timescale ndélais mpl

timescale time (Brit) n
 and the overall development risk." said Marek Myszko, business development manager, Drug Delivery at Cambridge Consultants. "A 40- to 60-percent reduction in time to market creates a significant competitive value and faster revenue to a company's bottom line in a market where generating market presence is particularly important."

The group of core Gen-X technologies being licensed by Cambridge Consultants include the technology to accurately pierce a foil blister blister, puffy swelling of the outer skin (epidermis) caused by burn, friction, or irritants like poison ivy. A response of the body to protect deeper tissue, blisters generally contain serum, the liquid component of blood. , evacuate e·vac·u·ate
v.
1. To empty or remove the contents of.

2. To excrete or discharge waste matter, especially of the bowels.
 the blister in a repeatable manner, and drug de-agglomerate technologies to provide tailored device performance. These, coupled with Cambridge Consultants' proven expertise in the development of solutions to technical challenges such as dose indexing and human factors, provide a quick development path for new DPIs.

Cambridge Consultants is highlighting its Gen-X DPI (Dots Per Inch) The measurement of the resolution of display and printing systems. A typical CRT screen provides 96 dpi, which provides 9,216 dots per square inch (96x96). Flat panel displays from 110 to 200 dpi have also been developed.  technologies at the Respiratory Drug Delivery 2008 conference (http://www.rddonline.com/rdd/rdd.php?id=3) in Scottsdale, Ariz., from May 11-15.

Images associated with this announcement can be found at: http://www.eml.com/images/cc029.jpg and http://www.eml.com/images/cc030.jpg.

About Cambridge Consultants

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology critical issues for clients worldwide. For nearly 50 years, the Years, The

the seven decades of Eleanor Pargiter’s life. [Br. Lit.: Benét, 1109]

See : Time
 company has enabled its clients to turn business opportunities into commercial successes, whether launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of over 250 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, automotive, transport, energy and wireless communications wireless communications

System using radio-frequency, infrared, microwave, or other types of electromagnetic or acoustic waves in place of wires, cables, or fibre optics to transmit signals or data.
. For more information visit: www.cambridgeconsultants.com.

Cambridge Consultants is part of the Altran group of companies. Altran Technologie, which is listed on the Paris Stock Exchange (FR:003463), employs more than 17,000 consultants in 20 countries around the world. In 2006 the group generated a turnover of EU1,495.6 million. For more information visit: www.altran.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Conference news
Date:May 12, 2008
Words:453
Previous Article:InnerWorkings Establishes Presence in Europe with Acquisition of UK-Based etrinsic.
Next Article:Brazauro to Acquire Bom Jardim Property in Brazil from Gold Fields.
Topics:



Related Articles
US DRUG DELIVERY SYSTEMS DEMAND TO INCREASE OVER 9% ANNUALLY THROUGH THE YEAR 2005.
Alliance and Inhale expand particle processing technology agreement.
Medical Technology Grades. (Supplier's Corner).
US drug delivery systems demand to reach over $82 billion in 2007.
INHALED-INSULIN TESTS PLANNED MANNKIND CORP. ENROLLING PATIENTS IN PHASE 3 SAFETY TRIAL.
Aerosol delivery devices in home care.
ZELOS/NEKTAR START PHASE 1 TRIAL OF INHALED OSTABOLIN-C.
INHALER DEVICES STILL A MAJOR HURDLE IN ASTHMA/COPD.
Make Breathing Fun Again with Playful Child & Pediatric Nebulizers

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles